Pradefovir Treatment for the Patients With Chronic Hepatitis B Virus Infections: a Phase3 Study
Clinical trial NCT04543565 · UNKNOWN
Trial details
- NCT number
- NCT04543565
- Sponsor
- Xi'an Xintong Pharmaceutical Research Co.,Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-10-01
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.